NMDA- but not AMPA-receptor antagonists augment scopolamine-induced spatial cognitive deficit of rats in a radial maze task

Brain Research

Volumn 725, Issue 2, 1996, Pages 268-271

  Li, Hong Bin ^a   Matsumoto, Kinzo ^a   Tohda, Michihisa ^a   Yamamoto, Minoru ^b   Watanabe, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

8 Arm radial maze; Augmentation; CGS19755; MK801; Scopolamine; Spatial cognitive deficit; YM90K

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; TASK PERFORMANCE;

EID: 0030181805     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00404-0     Document Type: Article

References (20)

1. [1] Bartus, R.T., Dean III, R.L., Beer, B. and Lippa, A.S., The cholinergic hypothesis of geriatric memory dysfunction, Science, 217 (1982) 408-417.
2. [2] Bliss, T.V.P. and Collingridge, G.L., A synaptic model of memory: long-term potentiation in the hippocampus, Nature, 361 (1993)31-39.
3. [3] Bockaert, J., Pin, J. and Fagni, L., Metabotropic glutamate receptors: an original family of G-protein-coupled receptors, Fund. Clin. Pharmacol., 7 (1993) 473-485.
4. [4] Butelman, N.R., A novel NMDA antagonist, MK801, impairs performance in a hippocampal-dependent spatial learning task, Pharmacol. Biochem. Behav., 34 (1989) 13-16.
5. [5] Challis, R.A., Mistry, R., Gray, D.W. and Nahorski, S.R., Modulation of muscarinic cholinoceptor-stimulated inositol-1,4,5-trisphosphate accumulation by NMDA in neonatal rat cerebral cortex, Neuropharmacol, 33 (1994) 15-25.
6. [6] Collingridge, G.L. and Lister, R.A.J., Excitatory amino acid receptors in the vertebrate nervous system, Pharmacol. Rev., 41 (1989) 2143-2210.
7. [7] Fibiger, H.C., Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence, Trends Neurosci., 14 (1991) 220-223.
8. [8] Harvey, J., Balasuramaniam, R and Collingridge, G.L., Carbachol can potentiate NMDA response in the rat hippocampus by a staurosporine and thapsigargin insensitive mechanism, Neurosci. Lett., 162 (1993) 165-168.
9. [9] Hasselmo, M.E. Schnell, E and Barkai, E., Dynamics of learning and recall at excitatory recurrent synapses and cholinergic modulation in rat hippocampal regions CA3, J. Neurosci., 15 (1995) 5249-5262.
10. [10] Hollmann, M. and Heinmann, S., Cloned glutamate receptors, Annu. Rev. Neurosci., 17 (1994) 31-108.
11. [11] Magnani, M., Pozzi, O., Biagetti, R., Banfi, S. and Dorigotti, L., Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze, Psychopharmacologia, 106 (1992) 175-178.
12. [12] Mcbain, C.J. and Mayer, M.L., N-methyl-D-aspartic acid receptor structure and function, Physiol. Rev., 74 (1994) 723-760.
13. [13] Mrzljak, L., Levey, A.I. and Goldman-Rakic, P.S., Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission, Proc. Natl. Acad. Sci. USA, 90 (1993) 5194-5198.
14. [14] Ohmori, J., Sakamoto, S., Kubota, H., Shimitsu-Sasamata, M., Okada, M., Kawasaki, S., Hidaka, K., Togami, J., Furuya, T. and Murase, K., 6-(1H-Imidazol-1-y1)-7-nitro-2,3-(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor, J. Med. Chem., 37 (1994) 467-475.
15. [15] Ohta, H., Matsumoto, K. and Watanabe, H., The interaction between central cholinergic and peripheral β-adrenergic systems on radial maze performance in rats, Brain Res., 622 (1993) 353.
16. [16] Olton, D.S. and Papas B.C., Spatial memory and hippocampal function, Neuropsychologia, 17 (1979) 669-682.
17. [17] Sato, K., Morimoto, K., Yamada, N., Kuroda, S. and Hayabara, T., NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo, Brain Res., 683 (1995) 279-282.
18. [18] Sheardown, M.J., Nielsen, E.O., Hansen, A.J., Jacobsen, P. and Honore, T., 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline: a neuroprotectant for cerebral ischemia, Science, 247 (1991) 571-574.
19. [19] Ward, J., Mason, S. E and Abraham, W. C., Effects of the NMDA antagonists CPP and MK801 on radial maze performance in rats, Pharmacol. Biochem. Behav., 35 (1989) 785-790.
20. [20] Wesnes, K., Simpson, P. and Kidd, A., An investigation of the range of cognitive impairments induced by scopolamine 0.6 mg s.c., Hum. Psychopharmacol., 3 (1988) 27-41.